1 小时
Zacks Investment Research on MSNHere's Why HCA Healthcare (HCA) is a Strong Momentum StockIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Agreement brings continued access to high-quality care for Alignment’s Medicare Advantage membersORANGE, Calif., March 18, 2025 (GLOBE ...
Independent ASCs are declining after decades of sinking reimbursement rates and soaring operational costs have forced ASC ...
Inhibrx Biosciences, Inc. ("Inhibrx" or the "Company") today reported financial results for the fourth quarter and fiscal year 2024. Following the completion of the sale of INBRX-101 by Inhibrx, Inc.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果